Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Puntoni

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Cancers|September 10, 2021
A Three-Domain Scoring System to Customize the Risk of Relapse of Differentiated Thyroid CarcinomaArnoldo Piccardo, Giacomo Siri, Martina Ugolini, et al.
Breast Cancer Research and Treatment|March 7, 2015
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studiesAlessandra Gennari, Mauro Costa, Matteo Puntoni, et al.
Tumori|June 14, 2005
Impact of concurrent radiotherapy on chemotherapy total dose and dose intensity in patients with early breast cancerCristina Marenghi, Pamela Guglielmini, Elena Verri, et al.
Oncology|July 16, 2005
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical studyElena Verri, Pamela Guglielmini, Matteo Puntoni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2026
Custom Made Three Dimensional Printed Models for Pre-operative Planning and Simulation of Endovascular Treatment of Peripheral Artery Disease (3DPAD-1): A Single Blind Randomised Controlled TrialPaolo Perini, Chiara Martini, Claudio Bianchini Massoni, et al.
Cancer Research|June 3, 2009
Estrogen receptor-beta affects the prognosis of human malignant mesotheliomaGiulia Pinton, Elisa Brunelli, Bruno Murer, et al.
Clinical Nuclear Medicine|December 18, 2012
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survivalArnoldo Piccardo, Federico Arecco, Matteo Puntoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trialsAlessandra Gennari, Martin Stockler, Matteo Puntoni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2016
Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non-Muscle-Invasive Bladder CancerMatteo Puntoni, Marilena Petrera, Sara Campora, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Cancers|September 10, 2021
A Three-Domain Scoring System to Customize the Risk of Relapse of Differentiated Thyroid CarcinomaArnoldo Piccardo, Giacomo Siri, Martina Ugolini, et al.
Breast Cancer Research and Treatment|March 7, 2015
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studiesAlessandra Gennari, Mauro Costa, Matteo Puntoni, et al.
Tumori|June 14, 2005
Impact of concurrent radiotherapy on chemotherapy total dose and dose intensity in patients with early breast cancerCristina Marenghi, Pamela Guglielmini, Elena Verri, et al.
Oncology|July 16, 2005
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical studyElena Verri, Pamela Guglielmini, Matteo Puntoni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapyAlessandra Gennari, Oriana Nanni, Matteo Puntoni, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2026
Custom Made Three Dimensional Printed Models for Pre-operative Planning and Simulation of Endovascular Treatment of Peripheral Artery Disease (3DPAD-1): A Single Blind Randomised Controlled TrialPaolo Perini, Chiara Martini, Claudio Bianchini Massoni, et al.
Cancer Research|June 3, 2009
Estrogen receptor-beta affects the prognosis of human malignant mesotheliomaGiulia Pinton, Elisa Brunelli, Bruno Murer, et al.
Clinical Nuclear Medicine|December 18, 2012
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survivalArnoldo Piccardo, Federico Arecco, Matteo Puntoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trialsAlessandra Gennari, Martin Stockler, Matteo Puntoni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2016
Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non-Muscle-Invasive Bladder CancerMatteo Puntoni, Marilena Petrera, Sara Campora, et al.
Pageof 14